시장보고서
상품코드
1286026

세계의 호르몬 대체요법(HRT) 시장 규모, 점유율, 성장 분석 : 요법 유형별, 적응증별, 투여 경로별 - 산업 예측(2023-2030년)

Global Hormone Replacement Therapy Market Size, Share, Growth Analysis, By Therapy Type, By Indication, By Route of Administration - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 165 Pages | 배송안내 : 3-5일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 호르몬 대체요법(HRT) 시장 규모는 2021년에 249억 7,000만 달러를 기록하고, 2022년 268억 7,000만 달러에서 2030년에는 492억 5,000만 달러가 될 것으로 예측됩니다. 2023년에서 2030년까지 예측기간 중 CAGR은 7.83%로 전망됩니다. 콜레스테롤치 상승, 혈전, 팽만감, 부기 등의 문제를 포함한 부작용 가능성이 시장 성장을 억제하고 있습니다.

세계의 호르몬 대체요법(HRT) 시장에 대해 조사했으며, 시장 개요, 시장 분석, 기업 개요 등의 정보를 제공합니다.

목차

주요 요약

상부 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
  • 성장 촉진요인
  • 기회
  • 성장 억제요인
  • 과제
  • 주요 시장 인사이트
  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • 지적재산 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공요인
  • 경쟁 정도
  • 시장 역학과 전망
  • 시장 역학
  • 성장 촉진요인
  • 기회
  • 성장 억제요인
  • 과제
  • 규제 상황
  • Porters 분석
  • 경쟁 기업간 경쟁 관계
  • 대체 제품의 위협
  • 구매자의 교섭력
  • 신규 참여업체의 위협
  • 공급 기업의 교섭력
  • 향후 혼란에 관한 Skyquest의 특별한 인사이트
  • 정치적 영향
  • 경제적 영향
  • 사회적 영향
  • 기술적 영향
  • 환경적 영향
  • 법적 영향
  • 세계의 호르몬 대체요법(HRT) 시장 : 요법 유형별
  • 시장 개요
  • 에스트로겐·병용 대체요법
  • 갑상선 호르몬 대체요법
  • 성장 호르몬 대체요법
  • 테스토스테론 호르몬 대체요법
  • 세계의 호르몬 대체요법(HRT) 시장 : 적응증별
  • 시장 개요
  • 폐경
  • 갑상선기능저하증
  • 남성성선기능저하증
  • 성장호르몬결핍증
  • 세계의 호르몬 대체요법(HRT) 시장 : 투여 경로별
  • 시장 개요
  • 경구
  • 경피
  • 비경구
  • 세계의 호르몬 대체요법(HRT) 시장 규모 : 지역별
  • 시장 개요
  • 북미
  • 미국
  • 캐나다
  • 유럽
  • 독일
  • 스페인
  • 프랑스
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 브라질
  • 기타 라틴아메리카
  • 중동 및 아프리카
  • GCC 국가
  • 남아프리카공화국
  • 기타 중동 및 아프리카
  • 경쟁 상황
  • 주요 5개사 비교
  • 주요 기업 시장에서의 포지셔닝(2021년)
  • 주요 시장 진출 기업이 채용한 전략
  • 주요 성공 전략
  • 개발별
  • 기업별
  • 연도별
  • 시장의 최근 활동
  • 주요 기업의 시장 점유율(%)(2021년)
  • 주요 기업 개요
  • Eli Lilly and Company(미국)
  • Bayer AG(독일)
  • Pfizer Inc.(미국)
  • Viatris, Inc.(미국)
  • Novo Nordisk A/S
  • Novartis International AG
  • Merck & Co. Inc.
  • Mylan N.V.
  • TherapeuticsMD Inc.
  • Abbott Laboratories
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Amgen Inc.
  • AbbVie Inc.
  • Ferring Pharmaceuticals
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Ipsen S.A.
  • Sanofi S.A.
KSM 23.06.15

Hormone Replacement Therapy (HRT) Market size was valued at USD 24.97 billion in 2021 and is poised to grow from USD 26.87 billion in 2022 to USD 49.25 billion by 2030, growing at a CAGR of 7.83% in the forecast period (2023-2030).

For many years, women with menopause-related disorders have been successfully treated with hormone replacement therapy. As a result, the risk of osteoporosis has decreased, as have other menopause symptoms including hot flashes. Due to the development in additional hormone-related ailments that are targeted at different age groups and affect both women and men, these therapies are also causing the market to grow. Therefore, it is anticipated that over the projection period, conditions like thyroid disorders, growth deficits, and others would speed up market expansion on a global scale.

The hormone replacement therapy (HRT) industry is growing as a result of factors like the availability of long-acting hGH products and the rising prevalence of target disorders. According to the American Thyroid Association, thyroid disease will affect 12% of Americans at some point in their lives. Furthermore, it mentioned that roughly 20 million Americans have thyroid illness. According to numerous studies, people on HRT presumably had a low risk of COVID-19 infection and mortality.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormone Replacement Therapy (HRT) Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Global hormone replacement therapy (HRT) market is segmented based on therapy type, indication and region. Based on therapy type, the market is segmented into estrogen & combinations replacement therapy, thyroid hormone replacement therapy, growth hormone replacement therapy, testosterone hormone replacement therapy segments. On the basis of indication, the market can be bifurcated into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency segments. Based on the route of administration, the market is segregated into oral, transdermal and parenteral route segments. The regional insights of the market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

Driver

People with growth hormone deficiency, menopausal symptoms in women, and hypogonadism in the elderly are among the many people who require the therapy. The drug is available in a variety of forms, such as skin and buccal patches, injections, tablets, and others. Producers are focusing on developing innovative medicine delivery systems, such as transdermal oestrogen patches and vaginal oestrogen pills, as a result of the rising use of these products around the world. In line with the safety worries, they are focusing more on the introduction of low dose oestrogen therapy than high dose oestrogen therapy. The key competitors in the global market have also embraced the launch of gel-based formulations for items like oestrogen patches.

Restraint

Market expansion is being negatively impacted by some issues. Patches, gel, pills, and injections are just a few of the several therapeutic formulations available. However, these medications' possible adverse effects, which include an increase in cholesterol levels, blood clots, bloating, swelling, and other issues, may limit market growth.

Additionally, it is projected that the adverse effects of testosterone replacement therapy, such as benign prostatic hyperplasia, obstructive sleep apnea, and prostate cancer, may restrain market growth. Due to the rise in cardiovascular disorders among patients undergoing testosterone replacement therapy, the US FDA has also expressed concern regarding the approved indication and the increasing incidences of cardiovascular risks associated with the products used in testosterone replacement therapy.

Market Trends

The growth in unmet demand for hormone replacement therapy in emerging countries and the greater awareness of the treatment of hormone issues are driving pharmaceutical companies to continuously bring new cutting-edge pharmaceuticals to the global market. In addition, the prevalence of menopause and diseases linked to hormone deficiency in developed countries has led manufacturers to develop new products such combination treatment solutions in place of the long-acting parenteral drugs that were formerly used daily.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Hormone Replacement Therapy (HRT) Market by Therapy Type
  • Market Overview
  • Estrogen & Combinations Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Growth Hormone Replacement Therapy
  • Testosterone Hormone Replacement Therapy
  • Global Hormone Replacement Therapy (HRT) Market by Indication
  • Market Overview
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Global Hormone Replacement Therapy (HRT) Market by Route of Administration
  • Market Overview
  • Oral
  • Transdermal
  • Parenteral
  • Global Hormone Replacement Therapy (HRT) Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Viatris, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • TherapeuticsMD Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Ipsen S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제